Literature DB >> 7836369

Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis.

N Shibata1, K Ikuta, T Imai, Y Satoh, R Satoh, A Suzuki, C Kojima, H Kobayashi, K Hisamichi, S Suzuki.   

Abstract

Isolation of side chain oligosaccharides from mannans of Candida albicans NIH B-792 (serotype B) and Candida parapsilosis IFO 1396 strains has been conducted by acetolysis under mild conditions. Structural study of these oligosaccharides by 1H and 13C NMR and methylation analyses indicated the presence of novel branched side chains with the following structures in C. albicans mannan. [sequence: see text] It was observed that the H-1 proton chemical shifts of the second and the third mannose units from the reducing terminus in each oligosaccharide are shifted upfield by substitution with an alpha-linked mannose unit at position 6 of the 3-O-substituted mannose unit. An agglutination inhibition assay between factor 4 serum and cells of Candida stellatoidea IFO 1397 lacking the beta-1,2-linked mannose unit, with oligosaccharides obtained from these mannans, indicated that only the branched oligosaccharides were active. This finding suggests that the branched oligosaccharides correspond to the epitope of antigenic factor 4. The presence of the branched structure in other mannans was detected by the characteristic H-1-H-2-correlated cross-peak of the alpha-1,2-linked mannose unit connected with the 3,6-di-O-substituted one by two-dimensional homonuclear Hartmann-Hahn spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836369     DOI: 10.1074/jbc.270.3.1113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  NMR comparison of hyphal and yeast Candida albicans serotype B mannans.

Authors:  Peter Bystrický; Eva Machová; Slavomír Bystrický
Journal:  Eur Biophys J       Date:  2018-04-13       Impact factor: 1.733

3.  The Candida albicans histidine kinase Chk1p: signaling and cell wall mannan.

Authors:  Dongmei Li; David Williams; Douglas Lowman; Mario A Monteiro; Xuan Tan; Michael Kruppa; William Fonzi; Elvira Roman; Jesus Pla; Richard Calderone
Journal:  Fungal Genet Biol       Date:  2009-06-27       Impact factor: 3.495

4.  Candida parapsilosis: an emerging pathogen developing its own identity.

Authors:  Joseph M Bliss
Journal:  Virulence       Date:  2015       Impact factor: 5.882

5.  NMR study of the galactomannans of Trichophyton mentagrophytes and Trichophyton rubrum.

Authors:  K Ikuta; N Shibata; J S Blake; M V Dahl; R D Nelson; K Hisamichi; H Kobayashi; S Suzuki; Y Okawa
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

6.  Specificity and prevalence of natural bovine antimannan antibodies.

Authors:  A Srinivasan; Y Ni; I Tizard
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Mannan structural complexity is decreased when Candida albicans is cultivated in blood or serum at physiological temperature.

Authors:  Douglas W Lowman; Harry E Ensley; Rachel R Greene; Kevin J Knagge; David L Williams; Michael D Kruppa
Journal:  Carbohydr Res       Date:  2011-10-02       Impact factor: 2.104

Review 8.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Minimum chemical requirements for adhesin activity of the acid-stable part of Candida albicans cell wall phosphomannoprotein complex.

Authors:  T Kanbe; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.